We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Predictive Drug Safety Models, Biomarkers Could Guide Industry
FDA Predictive Drug Safety Models, Biomarkers Could Guide Industry
July 29, 2011
The FDA plans to develop predictive models for preclinical drug safety and efficacy and identify more biomarkers to predict responses to these drugs — knowledge that could influence drugmakers’ development and marketing decisions.